157 related articles for article (PubMed ID: 14670093)
1. Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects.
Emanuele E; Peros E; Minoretti P; Falcone C; D'Angelo A; Montagna L; Geroldi D
BMC Cardiovasc Disord; 2003 Dec; 3():12. PubMed ID: 14670093
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.
Emanuele E; Peros E; Minoretti P; D'Angelo A; Piccinni MN; Montagna L; Geroldi D
Nutr Metab Cardiovasc Dis; 2004 Aug; 14(4):193-9. PubMed ID: 15553596
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts.
Hoogeveen RC; Gambhir JK; Gambhir DS; Kimball KT; Ghazzaly K; Gaubatz JW; Vaduganathan M; Rao RS; Koschinsky M; Morrisett JD
J Lipid Res; 2001 Apr; 42(4):631-8. PubMed ID: 11290835
[TBL] [Abstract][Full Text] [Related]
4. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension.
Gazzaruso C; Buscaglia P; Garzaniti A; Falcone C; Mariotti S; Savino S; Bonetti G; Finardi G; Geroldi D
J Hypertens; 1997 Mar; 15(3):227-35. PubMed ID: 9468449
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension.
Gazzaruso C; Buscaglia P; Garzaniti A; Bonetti G; Savino S; Mariotti S; Jucci A; Finardi G; Geroldi D
J Cardiovasc Risk; 1996 Apr; 3(2):191-7. PubMed ID: 8836862
[TBL] [Abstract][Full Text] [Related]
6. Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).
Saku K; Zhang B; Liu R; Shirai K; Arakawa K
Jpn Circ J; 1999 Sep; 63(9):659-65. PubMed ID: 10496479
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease.
Martín S; Pedro-Botet J; Joven J; Simó JM; Ladona MG; Pavesi M; Rubiés-Prat J
J Lab Clin Med; 2002 Mar; 139(3):181-7. PubMed ID: 11944029
[TBL] [Abstract][Full Text] [Related]
8. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age.
Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D
J Am Coll Cardiol; 1999 Jan; 33(1):157-63. PubMed ID: 9935023
[TBL] [Abstract][Full Text] [Related]
9. Apo(a) isoforms do not predict risk for coronary heart disease in a Gulf Arab population.
Akanji AO
Ann Clin Biochem; 2000 May; 37 ( Pt 3)():360-6. PubMed ID: 10817252
[TBL] [Abstract][Full Text] [Related]
10. Association of lipoprotein(a) concentration and apo(a) isoform size with restenosis after percutaneous transluminal coronary angioplasty.
Sirikci O; Aytekin V; Demiroglu IC; Demiroglu C; Marcovina SM
Int J Clin Lab Res; 2000; 30(2):93-9. PubMed ID: 11043503
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure.
Kronenberg F; Kuen E; Ritz E; Junker R; König P; Kraatz G; Lhotta K; Mann JFE; Müller GA; Neyer U; Riegel W; Riegler P; Schwenger V; VON Eckardstein A
J Am Soc Nephrol; 2000 Jan; 11(1):105-115. PubMed ID: 10616846
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein(a) isoforms and coronary heart disease in men: a nested case-control study.
Klausen IC; Sjøl A; Hansen PS; Gerdes LU; Møller L; Lemming L; Schroll M; Faergeman O
Atherosclerosis; 1997 Jul; 132(1):77-84. PubMed ID: 9247362
[TBL] [Abstract][Full Text] [Related]
13. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants.
Wild SH; Fortmann SP; Marcovina SM
Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):239-45. PubMed ID: 9081676
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G
J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.
Milionis HJ; Efstathiadou Z; Tselepis AD; Bairaktari ET; Tsironis LD; Tsatsoulis A; Elisaf MS
Thyroid; 2003 Apr; 13(4):365-9. PubMed ID: 12804105
[TBL] [Abstract][Full Text] [Related]
16. Apo(a) isoforms predict risk for coronary heart disease. A study in six populations.
Sandholzer C; Saha N; Kark JD; Rees A; Jaross W; Dieplinger H; Hoppichler F; Boerwinkle E; Utermann G
Arterioscler Thromb; 1992 Oct; 12(10):1214-26. PubMed ID: 1390593
[TBL] [Abstract][Full Text] [Related]
17. [Association of lipoprotein(a) and apolipoprotein(a) phenotypes with coronary and carotid atherosclerosis in CHD men].
Ezhov MV; Afanas'eva OI; Benevolenskaia GF; Savchenko AP; Balakhonova TV; Liakishev AA; Pokrovskiĭ SN
Ter Arkh; 2000; 72(1):28-32. PubMed ID: 10687202
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.
Peros E; Geroldi D; D'Angelo A; Falcone C; Montagna L; Carabela M; Emanuele E
Int J Mol Med; 2004 Feb; 13(2):243-7. PubMed ID: 14719130
[TBL] [Abstract][Full Text] [Related]
19. The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease.
Kalina A ; Császár A; Füst G; Nagy B; Szalai C; Karádi I; Duba J; Prohászka Z; Horváth L; Dieplinger H
Clin Chim Acta; 2001 Jul; 309(1):45-51. PubMed ID: 11408005
[TBL] [Abstract][Full Text] [Related]
20. Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study.
Brazier L; Tiret L; Luc G; Arveiler D; Ruidavets JB; Evans A; Chapman J; Cambien F; Thillet J
Atherosclerosis; 1999 Jun; 144(2):323-33. PubMed ID: 10407493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
